Rapport Therapeutics, Inc. · NASDAQ:RAPP

Cormorant Asset Management, LP reported a 6.35% stake in Rapport Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Cormorant Asset Management, LP reported a 6.35% stake in Rapport Therapeutics, Inc., 3,027,521 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
6.35%
Shares
3,027,521
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Cormorant Asset Management, LP6.35%3,027,521
Bihua Chen6.35%3,027,521

Source

View original at SEC

Related